# Catalent Pharma Solutions, LLC, Saint Petersburg, FL – FDA Inspections

Source: https://www.keypedia.com/companies/catalent-pharma-solutions-llc/d29a124f-fdcb-4108-9eac-661149b4d20e

> Inspection records and compliance data for Catalent Pharma Solutions, LLC in Saint Petersburg, Florida. 12 FDA inspections on record, 5 Form 483s, last inspected January 30, 2026.

---

## Details

- Name: Catalent Pharma Solutions, LLC
- FEI Number: 1811396
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: 2725 Scherer Dr N
- City: Saint Petersburg
- State: Florida
- Zip Code: 33716
- Country Name: United States
- Address: 2725 Scherer Dr N, Saint Petersburg, Florida 33716, United States
- Country: United States

## Related Documents

- [483 - Catalent Pharma Solutions, LLC - 2026-01-30](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/93c4cc9c-fd83-4c26-9023-0b4c62c93c56) — source: FDA, date: January 30, 2026
- [FDA Inspection 1282788 - Catalent Pharma Solutions, LLC - 2026-01-30](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/3c033b5d-6772-4e48-87f5-c003b37a8034) — source: FDA, date: January 30, 2026
- FDA Inspection 1282788 - Catalent Pharma Solutions, LLC - 2026-01-30 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 30, 2026
- FDA Inspection 1229815 - Catalent Pharma Solutions, LLC - 2024-05-30 — classification: No Action Indicated (NAI), source: FDA, date: May 30, 2024
- [FDA Inspection 1229344 - Catalent Pharma Solutions, LLC - 2024-01-25](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/89878bd4-947c-4510-8ccf-a1be0821f108) — classification: No Action Indicated (NAI), source: FDA, date: January 25, 2024
- [483 - Catalent Pharma Solutions, LLC - 2023-07-21](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/b53d3803-0505-4856-999c-33b3e1fb1bda) — source: FDA, date: July 21, 2023
- [FDA Inspection 1210540 - Catalent Pharma Solutions, LLC - 2023-07-21](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/90d4bb7b-c5b9-412b-9f5a-2300c5e0499b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 21, 2023
- [EIR - Catalent Pharma Solutions, LLC - 2019-08-28](https://www.keypedia.com/records/eir/catalent-pharma-solutions-llc/b67ab5e5-536c-40cb-a48e-316131669495) — source: FDA, date: August 28, 2019
- [FDA Inspection 1101180 - Catalent Pharma Solutions, LLC - 2019-08-28](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/75403390-fa81-4248-b533-acde008a2e64) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 28, 2019
- [483 - Catalent Pharma Solutions, LLC - 2019-02-22](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/c760f7e9-a3ed-4068-8e39-cf085acfd8af) — source: FDA, date: February 22, 2019
- [FDA Inspection 1080109 - Catalent Pharma Solutions, LLC - 2019-02-22](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/f65ec9d4-80a0-4c7e-8873-7b8eef0bdf8d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 22, 2019
- [483 - Catalent Pharma Solutions, LLC - 2018-06-14](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/c2a346ed-29f8-40bd-88dd-80e5da48f13c) — source: FDA, date: June 14, 2018
- [FDA Inspection 1056856 - Catalent Pharma Solutions, LLC - 2018-06-14](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/b2f1443c-74b0-4599-94e2-3f0c3724916b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 14, 2018
- [483 - Catalent Pharma Solutions, LLC - 2016-03-25](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/70f13562-b3ef-4e98-aae6-b2b576bd35e7) — source: FDA, date: March 25, 2016
- FDA Inspection 967738 - Catalent Pharma Solutions, LLC - 2016-03-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2016
- FDA Inspection 967738 - Catalent Pharma Solutions, LLC - 2016-03-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2016

## Related Companies

- [Pharmaceutics International, Inc.](https://www.keypedia.com/companies/pharmaceutics-international-inc/38fdf7bd-a7f3-486e-b74d-13b87414922e)
- [Fresenius Kabi USA, LLC](https://www.keypedia.com/companies/fresenius-kabi-usa-llc/6b662e1b-3996-48b4-a517-0d555d32a380)
- [Vetter Pharma Fertigung GmbH & Co. KG](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg/6b51041e-37a7-4672-a7e2-c3c871d6231b)
- [Sun Pharmaceutical Industries Ltd.](https://www.keypedia.com/companies/sun-pharmaceutical-industries-ltd/0ee9565e-1ff7-4ffa-b6ad-c38bccdc32e6)
- [ProSolus Inc](https://www.keypedia.com/companies/prosolus-inc/2a910759-3f32-4fe0-b770-d06ed9f0ee98)
- [Unilever Manufacturing (US), Inc.](https://www.keypedia.com/companies/unilever-manufacturing-us-inc/ae587d51-1cf8-4ced-af22-8da0d2758cf6)
- [Shiseido America Inc.](https://www.keypedia.com/companies/shiseido-america-inc/612a919a-3309-4649-b8bf-d8cd6af8ed5a)
- [Pyramid Laboratories, Inc.](https://www.keypedia.com/companies/pyramid-laboratories-inc/28e777be-a530-400a-97c6-9780ede4fb33)
- [Apertus Pharmaceuticals](https://www.keypedia.com/companies/apertus-pharmaceuticals/7436af25-9f52-43d1-a68e-002922496155)
- [BRS Analytical Services, LLC](https://www.keypedia.com/companies/brs-analytical-services-llc/841b237e-76fe-4854-a862-802339b3e528)

## Related Officers

- [Ileana Barreto-Petit](https://www.keypedia.com/people/ileana-barreto-petit/e5c865ac-14a2-47d4-954b-464a865e8684)
- [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [Christos G. Tsingelis](https://www.keypedia.com/people/christos-g-tsingelis/a0bacf2c-cf1f-4c34-996a-fcc1aa371610)
- [Jennifer Lalama](https://www.keypedia.com/people/jennifer-lalama/5ebc4da1-62ac-4b15-89a8-e18b0606e0ff)
- [Pharmacy Compounding National Expert, Drug Specialist, Drug Specialist, Foreign Cadre](https://www.keypedia.com/people/jessica-l-pressley/2c190e50-81bd-4015-95f0-7177beb363bd)